Vaccine Therapy Compared With Interferon Alfa in Treating Patients With Stage III Melanoma

Stopped early · Phase 2

Conditions studied: Melanoma (Skin)

In brief

RATIONALE: Vaccines made from a person's melanoma cells may make the body build an immune response to kill tumor cells. Interferon alfa may interfere with the growth of the cancer cells. PURPOSE: Randomized phase III trial to compare the effectiveness of melanoma vaccine with that of interferon alfa-2b in treating patients who have stage III melanoma that has spread to regional lymph nodes following surgery.

Key facts

Study ID
NCT00003715
Run by
AVAX Technologies
People needed
425
Starts
1998-12-01
Last updated by the study team
2015-12-03

Who can join

Age: 18 and older, up to 120. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.